BR1100667A - Benzimidazóis, medicamentos que contêm estes compostos e processos para sua preparação - Google Patents

Benzimidazóis, medicamentos que contêm estes compostos e processos para sua preparação

Info

Publication number
BR1100667A
BR1100667A BR1100667-6A BR1100667A BR1100667A BR 1100667 A BR1100667 A BR 1100667A BR 1100667 A BR1100667 A BR 1100667A BR 1100667 A BR1100667 A BR 1100667A
Authority
BR
Brazil
Prior art keywords
benzimidazoles
compounds
processes
preparation
drugs containing
Prior art date
Application number
BR1100667-6A
Other languages
English (en)
Inventor
Norbert Hauel
Berthold Narr
Uwe Ries
Jacques Van Meel
Wolfgang Wienen
Michael Entzeroth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR1100667A publication Critical patent/BR1100667A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR1100667-6A 1991-02-06 1997-05-07 Benzimidazóis, medicamentos que contêm estes compostos e processos para sua preparação BR1100667A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4103492A DE4103492A1 (de) 1991-02-06 1991-02-06 Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BR1100667A true BR1100667A (pt) 2000-06-13

Family

ID=6424446

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100667-6A BR1100667A (pt) 1991-02-06 1997-05-07 Benzimidazóis, medicamentos que contêm estes compostos e processos para sua preparação

Country Status (9)

Country Link
KR (1) KR100218820B1 (pt)
BR (1) BR1100667A (pt)
DE (4) DE4103492A1 (pt)
EE (1) EE03085B1 (pt)
NO (1) NO1999024I1 (pt)
TW (1) TW208015B (pt)
UA (1) UA35555C2 (pt)
YU (1) YU48849B (pt)
ZA (1) ZA92816B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan
CN113307775B (zh) * 2021-04-16 2022-04-22 河北戴桥医药科技有限公司 一种替米沙坦的制备方法

Also Published As

Publication number Publication date
UA35555C2 (uk) 2001-04-16
EE03085B1 (et) 1998-04-15
YU9892A (sh) 1999-03-04
DE4103492A1 (de) 1992-10-08
KR920016431A (ko) 1992-09-24
DE4117121A1 (de) 1992-12-17
TW208015B (pt) 1993-06-21
ZA92816B (en) 1993-07-05
NO1999024I1 (no) 1999-11-30
DE122011000013I1 (de) 2011-12-01
YU48849B (sh) 2002-06-19
KR100218820B1 (ko) 1999-09-01
DE4137812A1 (de) 1993-05-19

Similar Documents

Publication Publication Date Title
MX9205908A (es) Derivados heterobiarilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion
BR9708004A (pt) PirimidoÚ5,4¾pirimidinas medicamentos contendo estes compostos seu emprego e processos para sua preparação
BR9207000A (pt) Método para preparar drogas orais com proteção ao intestino contendo compostos instáveis em ácidos
MX9205064A (es) Heterociclos condensados de 5 miembros, procedimientos para su preparacion y medicamentos que contienen estos compuestos.
MX9206938A (es) Nuevos derivados peptidos, proceso para su preparacion y preparacion farmaceutica que comprende tales derivados.
NO953874D0 (no) Farmasöytisk preparat inneholdende lipofile legemidler
NO920067D0 (no) Foradditiv for droevtyggere
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
MX9200374A (es) Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene.
MX9202619A (es) Derivados de oxa tiolano cristalino, metodo para su preparacion y formulacion farmaceutica que los contiene.
MX9202748A (es) Compuesto de arileter, proceso para su obtencion y composicion farmaceutica que los contiene.
AR002982A1 (es) Benzonitrilos y benzofluoruros, un procedimiento para prepararlos, su empleo para preparar médicamentos, un médicamento hecho a base de estos compuestos, las preparaciónes farmacéuticas que los contienen y un procedimiento para obtener estas preparaciónes farmacéuticas.
BR9609327A (pt) Novos derivados de oxazolidinona processos para sua preparação e agentes farmacêuticos que contêm estes compostos
BR9101121A (pt) Composto,processo para sua preparacao,suas aplicacoes,e preparado farmaceutico
MX9201847A (es) Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen.
BR9303456A (pt) Compostos,processo para sua preparacao,medicamentos,processo para sua preparacao e emprego
MX9201848A (es) Antiserotoninas, procedimiento para su preparacion y medicamentos que las contienen.
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
BR1100667A (pt) Benzimidazóis, medicamentos que contêm estes compostos e processos para sua preparação
MX9200996A (es) Compuestos heterociclicos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9201846A (es) Polisacaridos sulfatados, procedimiento para su preparacion y composicion farmaceutica que los contiene.
MX9204239A (es) Quinolin-2-il-metoxibencilhindroxiureas, procedimiento para su preparacion y medicamentos que las contienen.
BR9202327A (pt) Composto heterociclico,processo para a sua preparacao,preparado farmaceutico e processo para a sua preparacao
BR9302359A (pt) Composto,processo para sua preparacao,medicamento e uso
MX9101594A (es) Compuestos de indenoidol,procedimiento para su preparacion y composicion farmaceutica que los contiene

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96
RLL Other requests - articles 230 and 231 of law 9279/96
B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-52400.000091/04 38A VARA FEDERAL DO RIO DE JANEIRO PROC. N2003.51.01.530651-2 CLASSE: 2005 TIPO: 2 IMPETRANTE: DR KARL THOMAE GMBH IMPETRADO: DIRETOR DE PANTENTES DO INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI DECISAO: PELO EXPOSTO, CONCEDO A SEGURANCA REQUERIDA, PARA DETERMINAR QUE A AUTORIDADE IMPETRADA PROMOVA A CORRECAO DO PRAZO DE VIGENCIA DA PATENTE BRASILEIRA PI 1100667-6, PELO PRAZO REMANESCENTE DE SUA CORRESPONDENTE ORIGINARIA, OU SEJA, O DIA 31 DE JANEIRO DE 2012, EM CONFORMIDADE COM O 4 DO ART. 230, DA LEI N 9.279/96. DETERMINO, AINDA, QUE SEJA PUBLICADA A CORRECAO DO PRAZO DE VALIDADE DA PATENTE EM QUESTAO NA REVISTA DA PROPRIEDADE INDUSTRIAL, BEM COMO SEJA EXPE

B23L Information on processing applications according to articles 230 and 231 of law 9.279/96 modified
B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-52400.000999/05 35A VARA FEDERAL DO RIO DE JANEIRO PROCESSO N2004.51.01.537418-2 MAN.: 0035.000429-2/2005 AUTOR: KARL THOMAE GMBH REU: INSTITUTO NACIONAL DE PROPRIEDADE INDUSTRIAL - INPI DECISAO: DIVULGAR EM SEU SITE OFICIAL E PUBLICAR NA RPI A INFORMACAO DE QUE O PRAZO DE VALIDADE DA PATENTE ORA EM DISCUSSAO E OBJETO DE UMA ACAO JUDICIAL, ISTO E, QUE A REFERIDA PATENTE ENCONTRA-SE SUB JUDICE.